Highlights
Recent News
Alphabet’s $218 Billion Legal Gamble Meets a Critical Earnings Test
A wave of mass arbitration claims, potentially worth over $218 billion, is set to crash against Alphabet Inc. just as...
Tesla’s Software Push Confronts a Mounting Inventory Glut
Tesla shares gained 1.82% to 307.20 EUR on Tuesday, a modest rally fueled by the rollout of its most extensive...
Coeur Mining’s Surging Stock Forces Short Sellers to Retreat
A dramatic 41% plunge in short interest during March tells a compelling story. Coeur Mining, having completed its transformative acquisition...
Broadcom’s AI Engine Drives Record Valuation Amid Insider Share Sales
Shares in semiconductor giant Broadcom have surged to a new peak, trading at €321.00 and delivering a staggering 104% gain...
Popular
Net Worth
Strategy’s $1 Billion Bitcoin Bet Defies Industry Exodus
While corporate Bitcoin purchases have nearly ground to a halt globally, one company continues its relentless accumulation....
Goldman’s $17.2 Billion Quarter and the Brutal Sorting of Everything Else
Dear readers, On Saturday we wrote that Tuesday's bank earnings would reveal whether Wall Street's fortress institutions...
BayWa’s Creditor Standoff and Asset Sale Saga Define Pivotal Year
The fate of German agricultural and energy group BayWa rests on a precarious convergence of events slated...
Replimune’s Lead Drug Hits Second FDA Wall, Triggering Survival Mode
The U.S. Food and Drug Administration has delivered a potentially fatal blow to Replimune Group Inc., issuing...